BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7211090)

  • 1. Plasma and urine free L-carnitine in human diabetes mellitus.
    De Palo E; Gatti R; Sicolo N; Padovan D; Vettor R; Federspil G
    Acta Diabetol Lat; 1981; 18(1):91-5. PubMed ID: 7211090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate.
    Melegh B; Kerner J; Jaszai V; Bieber LL
    Biochem Med Metab Biol; 1990 Feb; 43(1):30-8. PubMed ID: 2106908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urine carnitine in children with diabetes mellitus.
    Cederblad G; Hermansson G; Ludvigsson J
    Clin Chim Acta; 1982 Oct; 125(2):207-17. PubMed ID: 7139962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of kidney transplantation on carnitine metabolism.
    Kohse KP; Dech E; Rössle C; Franz HE; Fürst P
    Clin Nephrol; 1988 Apr; 29(4):199-205. PubMed ID: 3284670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assay of carnitine in plasma and urine of healthy adults].
    Niu YJ; Jiang ZM; Shu H; Li CF; Liu W; Yao GX; Jiang J; Li JQ; Longo A
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):185-7. PubMed ID: 12905800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postheparin plasma lipases and carnitine in infants during parenteral nutrition.
    Rovamo L
    Pediatr Res; 1985 Mar; 19(3):292-7. PubMed ID: 3920639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fasting on free and esterified carnitine levels in human serum and urine: correlation with serum levels of free fatty acids and beta-hydroxybutyrate.
    Frohlich J; Seccombe DW; Hahn P; Dodek P; Hynie I
    Metabolism; 1978 May; 27(5):555-61. PubMed ID: 642827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma levels of triglycerides, cholesterol, non-esterified fatty acids and uric acid, during oral glucose load, in subjects with type II diabetes and diminished glucose tolerance].
    Sinagra D; Botta RM; Lo Curzio E; Cerasola GA
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):964-70. PubMed ID: 6751356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urine levels of levocarnitine family components in genetically diabetic rats.
    Morabito E; Corsico N; Marzo A; Arrigoni Martelli E
    Arzneimittelforschung; 1994 Aug; 44(8):965-8. PubMed ID: 7945543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced lipid utilization in infants receiving oral L-carnitine during long-term parenteral nutrition.
    Helms RA; Whitington PF; Mauer EC; Catarau EM; Christensen ML; Borum PR
    J Pediatr; 1986 Dec; 109(6):984-8. PubMed ID: 3097293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral nutrition in preterm neonates with and without carnitine supplementation.
    Larsson LE; Olegård R; Ljung BM; Niklasson A; Rubensson A; Cederblad G
    Acta Anaesthesiol Scand; 1990 Aug; 34(6):501-5. PubMed ID: 2122630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in carnitine metabolism with ketone body production in obese glucose-intolerant patients.
    Inokuchi T; Imamura K; Nomura K; Nomoto K; Isogai S
    Diabetes Res Clin Pract; 1995 Oct; 30(1):1-7. PubMed ID: 8745200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia.
    Szefel J; Kruszewski WJ; Ciesielski M; Szajewski M; Kawecki K; Aleksandrowicz-Wrona E; Jankun J; Lysiak-Szydłowska W
    Oncol Rep; 2012 Jul; 28(1):319-23. PubMed ID: 22562434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of myocardial function in diabetic rats after treatment with L-carnitine.
    Paulson DJ; Schmidt MJ; Traxler JS; Ramacci MT; Shug AL
    Metabolism; 1984 Apr; 33(4):358-63. PubMed ID: 6708820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of carnitine in man.
    Maebashi M; Kawamura N; Sato M; Yoshinaga K; Suzuli M
    J Lab Clin Med; 1976 May; 87(5):260-6. PubMed ID: 178810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hormonal effects on carnitine metabolism in thin and obese subjects: responses to somatostatin, glucagon, and insulin.
    Genuth SM; Hoppel CL
    Metabolism; 1981 Apr; 30(4):393-401. PubMed ID: 6111018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low blood and plasma carnitine levels in children receiving long-term parenteral nutrition.
    Dahlström KA; Ament ME; Moukarzel A; Vinton NE; Cederblad G
    J Pediatr Gastroenterol Nutr; 1990 Oct; 11(3):375-9. PubMed ID: 2123243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycaemia-induced hyperinsulinaemia and alterations in high density lipoproteins in essential hypertension.
    Ligtenberg JJ; Van Tol A; Van Haeften TW; Sluiter WJ; Reitsma WD; Dullaart RP
    J Intern Med; 1996 Oct; 240(4):233-42. PubMed ID: 8918515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with L-carnitine in the post-stress phase].
    Balogh D; Hackl JM; Legenstein E; Musil HE
    Infusionsther Klin Ernahr; 1986 Oct; 13(5):204-8. PubMed ID: 3100446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketosis resistance in fibrocalculous pancreatic diabetes: II. Hepatic ketogenesis after oral medium-chain triglycerides.
    Yajnik CS; Sardesai BS; Bhat DS; Naik SS; Raut KN; Shelgikar KM; Orskov H; Alberti KG; Hockaday TD
    Metabolism; 1997 Jan; 46(1):1-4. PubMed ID: 9005960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.